Horsemen Advised To Avoid Adjunct Bleeder Meds

Monday, July 5, 2021
Monday, May 1, 2023

Effective immediately, horsemen are urged to discontinue the use of any and all adjunct bleeder medications for horses in training, including in particular, aminocaproic acid—commonly called Amicar.

Amicar and several other adjunct bleeder medications were placed on the Prohibited List in 2013 under the Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Code and the National Uniform Medication Program. Aminocaproic acid, for example, is a Class 4 substance and penalty Class C.

Latest Posts

Joint Industry Statement on HISA’s Proposed Rules Modifications

The MTHA is proud to stand alongside THA, TOBA, TOC, and KTA in a unified statement addressing HISA’s proposed modifications to the Anti-Doping and Medication Control Program.